arctigenin has been researched along with Allergic Encephalomyelitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, R; Guo, C; Lan, B; Li, Y; Shen, H; Wei, L; Xue, Z; Yuan, S; Zhang, R | 1 |
| Da, Y; Gu, C; Hao, J; Kong, Y; Li, W; Li, Y; Xue, Z; Yao, Z; Zhang, K; Zhang, L; Zhang, Q; Zhang, R; Zhang, Z | 1 |
2 other study(ies) available for arctigenin and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Arctigenin Exerts Neuroprotective Effect by Ameliorating Cortical Activities in Experimental Autoimmune Encephalomyelitis
Topics: Animals; Calcium; Encephalomyelitis, Autoimmune, Experimental; Excitatory Postsynaptic Potentials; Female; Furans; Lignans; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Somatosensory Cortex | 2021 |
Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling.
Topics: Adenylate Kinase; Animals; Cell Differentiation; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Female; Furans; Gene Expression Regulation; Lignans; Lymphoid Tissue; Mice, Inbred C57BL; Models, Biological; Nuclear Receptor Subfamily 1, Group F, Member 3; p38 Mitogen-Activated Protein Kinases; PPAR gamma; RNA, Messenger; Signal Transduction; Spinal Cord; Spleen; Th1 Cells; Th17 Cells | 2016 |